FibroGen Inc (FGEN)
0.3919
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 15:41
FibroGen Total Liabilities (Quarterly): 466.12M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 466.12M |
| June 30, 2024 | 483.58M |
| March 31, 2024 | 552.02M |
| December 31, 2023 | 585.73M |
| September 30, 2023 | 575.63M |
| June 30, 2023 | 575.43M |
| March 31, 2023 | 567.43M |
| December 31, 2022 | 611.57M |
| September 30, 2022 | 562.56M |
| June 30, 2022 | 563.04M |
| March 31, 2022 | 567.92M |
| December 31, 2021 | 544.71M |
| September 30, 2021 | 505.45M |
| June 30, 2021 | 528.77M |
| March 31, 2021 | 397.03M |
| December 31, 2020 | 385.39M |
| September 30, 2020 | 341.08M |
| June 30, 2020 | 392.54M |
| March 31, 2020 | 346.75M |
| December 31, 2019 | 321.99M |
| September 30, 2019 | 280.25M |
| June 30, 2019 | 266.76M |
| Date | Value |
|---|---|
| March 31, 2019 | 303.90M |
| December 31, 2018 | 352.13M |
| September 30, 2018 | 365.06M |
| June 30, 2018 | 355.12M |
| March 31, 2018 | 348.82M |
| December 31, 2017 | 350.91M |
| September 30, 2017 | 304.12M |
| June 30, 2017 | 293.27M |
| March 31, 2017 | 290.78M |
| December 31, 2016 | 294.44M |
| September 30, 2016 | 288.60M |
| June 30, 2016 | 286.75M |
| March 31, 2016 | 266.31M |
| December 31, 2015 | 273.75M |
| September 30, 2015 | 262.69M |
| June 30, 2015 | 268.51M |
| March 31, 2015 | 231.65M |
| December 31, 2014 | 242.85M |
| September 30, 2014 | 234.73M |
| June 30, 2014 | 232.79M |
| December 31, 2013 | 189.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
321.99M
Minimum
Dec 2019
611.57M
Maximum
Dec 2022
493.74M
Average
536.74M
Median
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 33.55M |
| GlycoMimetics Inc | 4.322M |
| Cidara Therapeutics Inc | 46.70M |
| Cue Biopharma Inc | 19.44M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.42M |
| Shareholders Equity (Quarterly) | -243.67M |
| Debt to Equity Ratio | -0.2987 |
| Current Ratio | 1.283 |
| Net Debt Paydown Yield | -0.68% |